Source: Sharecast
Travis Perkins, Wickes and Howden all rose after FTSE 100 peer Kingfisher lifted its full-year profit guidance despite weaker consumer sentiment, following strong interim trading.
Serco rose after saying it had appointed Michael LaRouche as chief executive of its North American division and announcing that MT&S has been selected as sole provider for training and simulator services to the US Air Force.
On the downside, Oxford Biomedica slid even as the biopharma reiterated full-year guidance and trimmed losses after seeing strong demand throughout the first half.
FTSE 250 - Risers
Travis Perkins (TPK) 593.50p 5.42%
B&M European Value Retail S.A. (DI) (BME) 257.70p 4.59%
Serco Group (SRP) 233.40p 4.57%
Frasers Group (FRAS) 738.50p 4.53%
Aston Martin Lagonda Global Holdings (AML) 83.00p 4.40%
NCC Group (NCC) 148.80p 4.20%
Helios Towers (HTWS) 148.00p 3.93%
Spire Healthcare Group (SPI) 244.50p 3.82%
Howden Joinery Group (HWDN) 870.00p 3.76%
Wickes Group (WIX) 217.00p 3.58%
FTSE 250 - Fallers
Oxford Biomedica (OXB) 601.00p -4.60%
Genus (GNS) 2,390.00p -2.05%
Chemring Group (CHG) 557.00p -1.76%
Oxford Nanopore Technologies (ONT) 158.60p -1.67%
Ashoka India Equity Investment Trust (AIE) 267.50p -1.47%
Syncona Limited NPV (SYNC) 97.00p -1.42%
Trustpilot Group (TRST) 226.80p -1.39%
C&C Group (CDI) (CCR) 144.00p -1.37%
Avon Technologies (AVON) 2,025.00p -1.22%
Kier Group (KIE) 209.50p -1.18%